Prevalence of plasmid-mediated quinolone resistance determinants in association with β-lactamases, 16S rRNA methylase genes and integrons amongst clinical isolates of Shigella flexneri

References

1. Cattoir V., Nordmann P.. ( 2009;). Plasmid-mediated quinolone resistance in Gram-negative bacterial species: an update. . Curr Med Chem 16:, 1028––1046. [CrossRef][PubMed]
   [Google Scholar]
2. CLSI ( 2010;). Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement. Document M100–S20. Wayne, PA.
3. Dallenne C., Da Costa A., Decré D., Favier C., Arlet G.. ( 2010;). Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae. . J Antimicrob Chemother 65:, 490––495. [CrossRef][PubMed]
   [Google Scholar]
4. Doi Y., Arakawa Y.. ( 2007;). 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. . Clin Infect Dis 45:, 88––94. [CrossRef][PubMed]
   [Google Scholar]
5. Dutta S., Kawamura Y., Ezaki T., Nair G. B., Iida K., Yoshida S.. ( 2005;). Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant Shigella dysenteriae serotype 1 clinical isolates from Kolkata, India. . Antimicrob Agents Chemother 49:, 1660––1661. [CrossRef][PubMed]
   [Google Scholar]
6. Hu L. F., Chang X., Ye Y., Wang Z. X., Shao Y. B., Shi W., Li X., Li J. B.. ( 2011;). Stenotrophomonas maltophilia resistance to trimethoprim/sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron. . Int J Antimicrob Agents 37:, 230––234. [CrossRef][PubMed]
   [Google Scholar]
7. Kado C. I., Liu S. T.. ( 1981;). Rapid procedure for detection and isolation of large and small plasmids. . J Bacteriol 145:, 1365––1373.[PubMed]
   [Google Scholar]
8. Kotloff K. L., Winickoff J. P., Ivanoff B., Clemens J. D., Swerdlow D. L., Sansonetti P. J., Adak G. K., Levine M. M.. ( 1999;). Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. . Bull World Health Organ 77:, 651––666.[PubMed]
   [Google Scholar]
9. Luo Y. P., Yang J. Y., Zhang Y. J., Ye L. Y., Wang L. L., Guo L.. ( 2011;). Prevalence of β-lactamases and 16S rRNA methylase genes amongst clinical Klebsiella pneumoniae isolates carrying plasmid-mediated quinolone resistance determinants. . Int J Antimicrob Agents 37:, 352––355. [CrossRef][PubMed]
   [Google Scholar]
10. Niyogi S. K.. ( 2007;). Increasing antimicrobial resistance – an emerging problem in the treatment of shigellosis. . Clin Microbiol Infect 13:, 1141––1143. [CrossRef][PubMed]
    [Google Scholar]
11. Wang M., Tran J. H., Jacoby G. A., Zhang Y., Wang F., Hooper D. C.. ( 2003;). Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. . Antimicrob Agents Chemother 47:, 2242––2248. [CrossRef][PubMed]
    [Google Scholar]
12. Xiong Z., Li J., Li T., Shen J., Hu F., Wang M.. ( 2010;). Prevalence of plasmid-mediated quinolone-resistance determinants in Shigella flexneri isolates from Anhui Province, China. . J Antibiot (Tokyo) 63:, 187––189. [CrossRef][PubMed]
    [Google Scholar]
13. Yamane K., Wachino J., Suzuki S., Kimura K., Shibata N., Kato H., Shibayama K., Konda T., Arakawa Y.. ( 2007;). New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. . Antimicrob Agents Chemother 51:, 3354––3360. [CrossRef][PubMed]
    [Google Scholar]